Detrol: Agent for an Overactive Bladder

An overactive bladder can prove to be an embarrassing situation. Not only is it embarrassing, but extremely uncomfortable. If you have gone to your doctor for help concerning an overactive bladder, he/she may have recommended that you take Detrol (Tolterodine Tartrate). Detrol (Tolterodine Tartrate) comes in tablet and capsule form. The tablets are white, and come in the strengths of one milligram, and two milligrams. The capsules are extended release (Detrol LA), and the two milligram strength comes in a blue/green capsule, while the four milligram strength comes in the blue capsule.

Detrol (Tolterodine Tartrate) is used to treat patients who have an overactive bladder with the symptoms that come with having such a disorder, such as urinary urgency and frequency, and even urinary incontinence. To begin taking Detrol (Tolterodine Tartrate), the recommended beginning dose is for milligrams a day in one four milligram dose if you are taking Detrol LA, or two regular Detrol (Tolterodine Tartrate) doses. The dose of Detrol (Tolterodine Tartrate) can be lowered by your doctor depending on how the medication reacts in your body, and how well your body tolerates it. Use one milligram of Detrol (Tolterodine Tartrate) twice a day or take Detrol LA 2 mg once a day if you are a patient with impaired hepatic function and if you're taking drugs that stop the action of cytochrome P450 in your liver. The Tolterodine in Detrol slows down the movement in the urinary tract and calms the related muscles. Maximum concentrations of Detrol (Tolterodine Tartrate) occurs in one to two hours, and in Detrol LA, maximum concentrations happen after four to six hours since it is an extended release medication. If you are taking any medications that include ketoconazole, itraconazole, miconazole, erythromycin, clarithromycin, cyclosporine, or vinblastine, levels of Tolterodine in Detrol may increase in patients that are poor metabolizers. Patients that are poor metabolizers are patients who do not have CYP2D6.